You are here
Home > Drug classes > HIV (anti) Agents

Drug Classes

Combination Products Nucleoside Reverse Transcriptase Inhibitors Non-Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors All other classes (e.g. Fusion inhibitors, CCR5 Antagonists, integrase strand transfer inhibitors) Infectious Disease -ALL Agents (INDEX)
DisclaimerPlease see package insert if applicable for additional information. The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.   Read the disclaimer   |   <BACK

Combination Products

Atripla™ (Efavirenz, emtricitabine, and tenofovir)
Combivir ® (AZT 300mg+150 mg lamivudine)
COMPLERA® (emtricitabine/ rilpivirine/tenofovir disoproxil fumarate)
Epzicom ® (abacavir 600mg + lamivudine 300mg)
STRIBILD™ (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate)
Trizivir ® (abacavir 300mg + lamivudine 150mg + zidovudine 300mg)
Truvada ® (emtricitabine 200mg + tenofovir 300mg)   

Nucleoside Reverse Transcriptase Inhibitors

Abacavir (Ziagen ®)
Atripla™ (Efavirenz, emtricitabine, and tenofovir)
Combivir ® (AZT 300mg+150 mg lamivudine)
Didanosine (Videx ®) emtricitabine (Emtriva ®)
Epzicom ® (abacavir 600mg + lamivudine 300mg)
Lamivudine (Epivir ®)
Stavudine (Zerit ® )
Tenofovir (Viread ®)
Trizivir ® (abacavir 300mg + lamivudine 150mg + zidovudine 300mg)
Truvada ® (emtricitabine 200mg + tenofovir 300mg)
Zalcitabine (Hivid ® )
Zidovudine (Retrovir ® )  

Non-Nucleoside Reverse Transcriptase Inhibitors

Delavirdine (Rescriptor ®)
Efavirenz (Sustiva ® )
Etravirine – INTELENCE®
Nevirapine (Viramune ®)
Rilpivirine hydrochloride – EDURANT™

Protease Inhibitors

Amprenavir (Agenerase ® )
Atazanavir (Reyataz ® )
Darunavir (Prezista™)
Fosamprenavir (Lexiva ® )
Indinavir (Crixivan ® )
Kaletra ® (Lopinavir 133 mg + Ritonavir 33.3 mg )
Nelfinavir (Viracept ®)
Ritonavir (Norvir ®)
Saquinavir (Fortovase® ,Invirase ®)
Tipranavir (Aptivus ® )

Fusion inhibitors, CCR5 Antagonists, integrase strand transfer inhibitors

dolutegravir -TIVICAY®
Enfuvirtide (Fuzeon ®)
Maraviroc (Selzentry™)
Raltegravir (Isentress ®)  

Reference(s)

National Institutes of Health, U.S. National Library of Medicine, DailyMed Database.
Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates.  A local search option of this data can be found here.

Disclaimer

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer